← Back to headlines
Apellis Pharma Stock Surges Following Biogen Deal
Apellis Pharma's stock has seen a significant surge following a deal with Biogen, leading investors to question if it's too late to capitalize on the APLS stock rally.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
